Rituximab und Lenalidomid zur Behandlung des follikulären Lymphoms
Crossref DOI link: https://doi.org/10.1007/s15004-018-6262-6
Published Online: 2018-11-08
Published Print: 2018-11
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Hiller, Erhard
Text and Data Mining valid from 2018-11-01
Article History
First Online: 8 November 2018